ICMR to conduct trials of indigenously developed Zika vaccine

ICMR will undertake phase-II trial of the vaccine to establish the efficacy and safety of the vaccine along with its adverse effects.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2PyvU9w
via IFTTT